QQQ   423.41 (-0.57%)
AAPL   167.04 (-0.57%)
MSFT   404.27 (-1.84%)
META   501.80 (+1.54%)
GOOGL   156.01 (+0.35%)
AMZN   179.22 (-1.14%)
TSLA   149.93 (-3.55%)
NVDA   846.71 (+0.76%)
AMD   155.08 (+0.69%)
NIO   4.00 (+2.30%)
BABA   68.88 (+0.09%)
T   16.33 (+1.30%)
F   12.06 (+0.17%)
MU   111.93 (-3.78%)
GE   152.94 (-1.75%)
CGC   7.83 (+20.65%)
DIS   112.43 (-0.45%)
AMC   2.92 (-2.01%)
PFE   25.39 (-0.12%)
PYPL   62.10 (-1.83%)
XOM   118.52 (-0.09%)
QQQ   423.41 (-0.57%)
AAPL   167.04 (-0.57%)
MSFT   404.27 (-1.84%)
META   501.80 (+1.54%)
GOOGL   156.01 (+0.35%)
AMZN   179.22 (-1.14%)
TSLA   149.93 (-3.55%)
NVDA   846.71 (+0.76%)
AMD   155.08 (+0.69%)
NIO   4.00 (+2.30%)
BABA   68.88 (+0.09%)
T   16.33 (+1.30%)
F   12.06 (+0.17%)
MU   111.93 (-3.78%)
GE   152.94 (-1.75%)
CGC   7.83 (+20.65%)
DIS   112.43 (-0.45%)
AMC   2.92 (-2.01%)
PFE   25.39 (-0.12%)
PYPL   62.10 (-1.83%)
XOM   118.52 (-0.09%)
QQQ   423.41 (-0.57%)
AAPL   167.04 (-0.57%)
MSFT   404.27 (-1.84%)
META   501.80 (+1.54%)
GOOGL   156.01 (+0.35%)
AMZN   179.22 (-1.14%)
TSLA   149.93 (-3.55%)
NVDA   846.71 (+0.76%)
AMD   155.08 (+0.69%)
NIO   4.00 (+2.30%)
BABA   68.88 (+0.09%)
T   16.33 (+1.30%)
F   12.06 (+0.17%)
MU   111.93 (-3.78%)
GE   152.94 (-1.75%)
CGC   7.83 (+20.65%)
DIS   112.43 (-0.45%)
AMC   2.92 (-2.01%)
PFE   25.39 (-0.12%)
PYPL   62.10 (-1.83%)
XOM   118.52 (-0.09%)
QQQ   423.41 (-0.57%)
AAPL   167.04 (-0.57%)
MSFT   404.27 (-1.84%)
META   501.80 (+1.54%)
GOOGL   156.01 (+0.35%)
AMZN   179.22 (-1.14%)
TSLA   149.93 (-3.55%)
NVDA   846.71 (+0.76%)
AMD   155.08 (+0.69%)
NIO   4.00 (+2.30%)
BABA   68.88 (+0.09%)
T   16.33 (+1.30%)
F   12.06 (+0.17%)
MU   111.93 (-3.78%)
GE   152.94 (-1.75%)
CGC   7.83 (+20.65%)
DIS   112.43 (-0.45%)
AMC   2.92 (-2.01%)
PFE   25.39 (-0.12%)
PYPL   62.10 (-1.83%)
XOM   118.52 (-0.09%)
Free Trial
NASDAQ:SBBP

Strongbridge Biopharma (SBBP) Stock Price, News & Analysis

→ This company has increased its dividend every year for 54 years (From DTI) (Ad)
Free SBBP Stock Alerts
Notice: This company has been marked as potentially delisted and may not be actively trading.
Compare
Today's Range
$1.95
▼
$2.06
50-Day Range
$1.89
▼
$2.29
52-Week Range
$1.85
▼
$4.26
Volume
684,684 shs
Average Volume
866,464 shs
Market Capitalization
$135.66 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Stock Analysis
Stock Analysis
SBBP stock logo

About Strongbridge Biopharma Stock (NASDAQ:SBBP)

Strongbridge Biopharma Plc operates as a commercial-stage biopharmaceutical company, which focuses on the development and commercialization of therapies for rare diseases. Its pipeline is comprised of Keveyis, Macrilen, Recorlev, and Veldoreotide. The company was founded in 1996 and is headquartered in Trevose, PA.

SBBP Stock News Headlines

February 10, 2024 | investing.com
Matinas BioPharma Holdings Inc (MTNB)
November 15, 2023 | lse.co.uk
Lytix Biopharma As Share Price (LYTIX.OL)
April 18, 2024 | DTI (Ad)
Special FREE offer on stock hotsheets
These sheets tell you the exact day you should consider buying a stock… And the exact day you should consider selling it… All based on TEN YEARS of historic data and trends. For example, like January 6th through the 12th with Apple… It’s gone up every single year for the last decade. Or like May 26th through June 11th with LULU… Again - it’s gone up every single year for the last decade. Then there’s July 1st through the 21st with Walmart… What happened to WMT?
November 4, 2023 | morningstar.com
Ambrx Biopharma Inc AMAM
August 19, 2023 | seekingalpha.com
HILS Hillstream BioPharma, Inc.
July 1, 2023 | finance.yahoo.com
ABUS - Arbutus Biopharma Corporation
April 25, 2023 | thestreet.com
The Nominees for Best Biopharma CEO of 2015 Are...
January 11, 2023 | marketwatch.com
Day One Biopharma Shares Rise 13% After Positive Topline Results for Tovorafenib
April 18, 2024 | DTI (Ad)
A new way to collect income from stocks
Most people think of BUYING options when they talk about options. It’s how speculators leverage large sums of money hoping that a stock moves in the “right” direction over a certain period of time. The problem is - they don’t always pay off when you buy them. In fact, a contributing writer at the Financial Post studied options extensively…
September 22, 2022 | markets.businessinsider.com
Accord BioPharma Partners with StoryMD to Deliver Advanced Prostate Cancer Educational Content to Clinicians and Patients
September 23, 2021 | apnews.com
Strongbridge Biopharma plc Announces Court Hearing Date to Approve Proposed Acquisition by ...
September 23, 2021 | finance.yahoo.com
Strongbridge Biopharma plc Announces Court Hearing Date to Approve Proposed Acquisition by Xeris Pharmaceuticals, Inc.
September 14, 2021 | stockhouse.com
Xeris Pharmaceuticals Stockholders Approve Acquisition of Strongbridge Biopharma
September 9, 2021 | apnews.com
Strongbridge Biopharma plc Announces Shareholder Approval of Proposed Acquisition by Xeris ...
August 31, 2021 | apnews.com
Leading Independent Proxy Advisory Firm ISS Recommends Strongbridge Biopharma plc Shareholders ...
August 31, 2021 | finance.yahoo.com
Second Leading Independent Proxy Advisory Firm Glass Lewis Recommends Strongbridge Biopharma plc Shareholders Vote “FOR” the Transaction With Xeris
August 5, 2021 | sfgate.com
Strongbridge Biopharma: Q2 Earnings Snapshot
August 5, 2021 | finance.yahoo.com
Strongbridge Biopharma plc Reports Second Quarter 2021 Financial Results and Provides Corporate Update
August 2, 2021 | finance.yahoo.com
Strongbridge Biopharma plc Announces Commencement of Mailing of Proxy Statement
July 29, 2021 | finance.yahoo.com
Strongbridge Biopharma plc to Report Second Quarter 2021 Financial Results on August 5, 2021
July 29, 2021 | finance.yahoo.com
Strongbridge Biopharma plc Provides Announcement Under the Irish Takeover Rules for Relevant Securities in Issue
July 28, 2021 | nasdaq.com
Strongbridge Biopharma's (NASDAQ:SBBP) Stock Price Has Reduced 48% In The Past Three Years
July 27, 2021 | finance.yahoo.com
Strongbridge Biopharma (SBBP) May Report Negative Earnings: Know the Trend Ahead of Q2 Release
July 27, 2021 | apnews.com
Strongbridge Biopharma plc Announces Dates of Special Shareholder Meetings in Connection with ...
July 26, 2021 | msn.com
BRIEF-Strongbridge Biopharma Plc, Unit, Avenue Venture Opportunities Fund Enter Amendment To A Term Loan Agreement
See More Headlines
Receive SBBP Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Strongbridge Biopharma and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
8/05/2021
Today
4/18/2024
Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Pharmaceutical Preparations
Sub-Industry
N/A
Current Symbol
NASDAQ:SBBP
CUSIP
N/A
CIK
1634432
Web
www.strongbridgebio.com
Phone
(610) 254-9200
Fax
N/A
Employees
72
Year Founded
N/A

Profitability

EPS (Most Recent Fiscal Year)
($0.78)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
$-45,080,000.00
Net Margins
-115.67%
Pretax Margin
N/A
Return on Equity
-66.82%
Return on Assets
-36.21%

Debt

Debt-to-Equity Ratio
0.38
Current Ratio
3.00
Quick Ratio
2.95

Sales & Book Value

Annual Sales
$30.73 million
Price / Sales
4.41
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$0.98 per share
Price / Book
2.04

Miscellaneous

Outstanding Shares
67,829,000
Free Float
N/A
Market Cap
$135.66 million
Optionable
Optionable
Beta
1.58
The Next 7 Blockbuster Stocks for Growth Investors Cover
The Next 7 Blockbuster Stocks for Growth Investors

Wondering what the next stocks will be that hit it big, with solid fundamentals? Click the link below to learn more about how your portfolio could bloom.

Get This Free Report

Key Executives

  • John H. Johnson
    Chief Executive Officer & Director
  • Richard S. Kollender
    President & Chief Financial Officer
  • Fredric Cohen
    Chief Medical Officer
  • Brian Conner
    Chief Compliance Officer
  • Peter J. Valentinsson
    Senior Vice President-Global Technical Operations

Key Competitors

View All Competitors

SBBP Stock Analysis - Frequently Asked Questions

How were Strongbridge Biopharma's earnings last quarter?

Strongbridge Biopharma plc (NASDAQ:SBBP) released its earnings results on Thursday, August, 5th. The biotechnology company reported ($0.21) EPS for the quarter, missing the consensus estimate of ($0.12) by $0.09. The biotechnology company earned $10.04 million during the quarter, compared to analysts' expectations of $8.83 million. Strongbridge Biopharma had a negative trailing twelve-month return on equity of 66.82% and a negative net margin of 115.67%.

What other stocks do shareholders of Strongbridge Biopharma own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Strongbridge Biopharma investors own include SCYNEXIS (SCYX), Sorrento Therapeutics (SRNE), VBI Vaccines (VBIV), Energy Transfer (ET), Selecta Biosciences (SELB), Rigel Pharmaceuticals (RIGL), Agile Therapeutics (AGRX), Dicerna Pharmaceuticals (DRNA), Dynavax Technologies (DVAX) and Matinas BioPharma (MTNB).

This page (NASDAQ:SBBP) was last updated on 4/18/2024 by MarketBeat.com Staff

From Our Partners
[Urgent!] Generational Wealth Gameplan
Crypto 101 Media
The “Perfect Storm” for Gold
Gold Safe Exchange
Biden’s $374B Giveaway Into This Sector
DTI
He Is Giving Away Bitcoin
Crypto Swap Profits
Forget Bitcoin. Crypto Millionaire Predicts 8,788% Gains For THIS
Paradigm Press
Your Money is Not Safe
American Alternative
The Next Nvidia?
InvestorPlace
Top 5 AI Stocks to Buy for 2024
Market Moving Trends